MPS IVA

3

Review clinical trials related to MPS IVA. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Non-invasive Functional Assessment and Pathogenesis of Morquio A

Morquio A disease is a devastating systemic skeletal disease in which detailed progression and pathogenesis remain unknown. The proposed project aims to establish a non-invasive objective assessment that can be applicable to all ages of patients to better understand the progress of their disease and the most serious clinical problems (cervical instability and stenosis, tracheal obstruction, hyperlaxity of joints, hip dysplasia, and small lung capacity). The outcome of this project will lead to a more precise understanding of the skeletal/pulmonary compromise and defining clinical endpoints in this disease for future clinical trials of current or developing therapies.

Participants needed: 60
Trial details
Biological sex: AllType: ObservationalSponsor: Nemours Children's ClinicUpdated: May 13, 2026Locations: 1
Eligibility criteria

Patients affected by MPS IVA. The diagnosis of MPS IVA is confirmed by deficient...

No

Status: Recruiting

PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)

For detailed information, please view our study website: https://pearltrial.ucsf.edu/ The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.

Participants needed: 10
Trial details
Phase: Phase 1Age: 18-50Biological sex: FemaleType: InterventionalSponsor: University of California, San FranciscoUpdated: Mar 17, 2026Locations: 1
Eligibility criteria

Live male or female fetuses at 18 0/7 weeks to 34 6/7 weeks gestation [+4]

Fetuses with a concurrent severe structural anomaly [+10]

Status: Recruiting

Cardiac Structure and Function in MPS

The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are looking at certain substances in the body called GAGs and proteoglycans to see how they affect the heart. The investigators also want to find reliable blood and urine markers that can help us track heart health and guide future treatments. This study aims to answer two main questions: 1. Do people with MPS show faster changes in their blood vessels over time (such as thickening or stiffening of the carotid artery) compared to people without MPS? 2. Do people with MPS have higher levels of certain proteins in their blood (such as clusterin and inflammatory markers) that are linked to blood vessel changes? What participants will do? Participants will complete the following tests once a year for 4 years: * Carotid ultrasound: an imaging test that looks at the blood vessels in the neck. * Echocardiogram: an ultrasound of the heart. * Blood draw * Urine collection These tests help the investigators track changes in heart and blood vessel health over time.

Participants needed: 240
Trial details
Age: 0-99Biological sex: AllType: ObservationalSponsor: Children's Hospital of Orange CountyUpdated: Jan 26, 2026Locations: 3
Eligibility criteria

Any Participant with a molecularly confirmed diagnosis of mucopolysaccharidosis... [+2]

Any reason that the investigators would deem a patient not eligible to participa... [+1]